Is There an Obesity Paradox for Outcomes in Atrial Fibrillation? A Systematic Review and Meta-Analysis of Non–Vitamin K Antagonist Oral Anticoagulant Trials
M Proietti, E Guiducci, P Cheli, GYH Lip - Stroke, 2017 - Am Heart Assoc
Background and Purpose—Obesity is a risk factor for all-cause and cardiovascular death
but, despite this, an inverse relationship between overweight or obesity and a better …
but, despite this, an inverse relationship between overweight or obesity and a better …
Non-vitamin K antagonist oral anticoagulant for atrial fibrillation in obese patients
SY Wang, RP Giugliano - The American Journal of Cardiology, 2020 - Elsevier
Highlights•Obesity is an important risk factor for atrial fibrillation.•Despite “obesity paradox”
in atrial fibrillation, patient weight loss preferred.•Oral anticoagulants may be more …
in atrial fibrillation, patient weight loss preferred.•Oral anticoagulants may be more …
Association of body mass index with clinical outcomes in patients with atrial fibrillation: a report from the FANTASIIA registry
V Bertomeu‐Gonzalez, J Moreno‐Arribas… - Journal of the …, 2020 - Am Heart Assoc
Background Obesity and atrial fibrillation (AF) frequently coexist and independently increase
mortality. We sought to assess the association between obesity and adverse events in …
mortality. We sought to assess the association between obesity and adverse events in …
Body mass index and adverse outcomes in elderly patients with atrial fibrillation: the AMADEUS trial
K Senoo, GYH Lip - Stroke, 2016 - Am Heart Assoc
Background and Purpose—Obesity has been associated with increased cardiovascular risk
in atrial fibrillation, but little is known in elderly patients with atrial fibrillation. Methods—Post …
in atrial fibrillation, but little is known in elderly patients with atrial fibrillation. Methods—Post …
The obesity paradox for outcomes in atrial fibrillation: Evidence from an exposure‐effect analysis of prospective studies
The impact of obesity on the prognosis of atrial fibrillation (AF) remains controversial. We
conducted an exposure‐effect meta‐analysis of prospective studies to clarify the relationship …
conducted an exposure‐effect meta‐analysis of prospective studies to clarify the relationship …
The 'obesity paradox'in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) …
RK Sandhu, J Ezekowitz, U Andersson… - European Heart …, 2016 - academic.oup.com
Aims The prognostic implication of adiposity on clinical outcomes in atrial fibrillation (AF)
patients treated with oral anticoagulation is unclear. Methods and results A total of 17 913 …
patients treated with oral anticoagulation is unclear. Methods and results A total of 17 913 …
Increased risk of major bleeding in underweight patients with atrial fibrillation who were prescribed non-vitamin K antagonist oral anticoagulants
Background There is a paucity of evidence regarding the effects of non-vitamin K antagonist
oral anticoagulants (NOACs) in underweight patients with atrial fibrillation (AF). Objective …
oral anticoagulants (NOACs) in underweight patients with atrial fibrillation (AF). Objective …
Meta-analysis comparing direct oral anticoagulants versus warfarin in morbidly obese patients with atrial fibrillation
K Kido, M Shimizu, T Shiga, M Hashiguchi - The American journal of …, 2020 - Elsevier
Highlights•Direct oral anticoagulants did not increase stroke or systemic embolism event
rate.•Direct oral anticoagulants had lower major bleeding rate than warfarin.•Direct oral …
rate.•Direct oral anticoagulants had lower major bleeding rate than warfarin.•Direct oral …
Efficacy and Safety of Non–Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual …
BACKGROUND: The efficacy and safety of non–vitamin-K antagonist oral anticoagulants
(NOACs) across the spectrum of body mass index (BMI) and body weight (BW) remain …
(NOACs) across the spectrum of body mass index (BMI) and body weight (BW) remain …
[HTML][HTML] Effects of body mass index on risks for ischemic stroke, thromboembolism, and mortality in Chinese atrial fibrillation patients: a single-center experience
HJ Wang, QJ Si, ZL Shan, YT Guo, K Lin, XN Zhao… - PLoS …, 2015 - journals.plos.org
Background Obesity is considered to be related to recurrence of atrial fibrillation (AF), left
atrial thrombus formation, and atrial remodeling. However, whether obesity is an …
atrial thrombus formation, and atrial remodeling. However, whether obesity is an …